Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.00

+0.50 (0.93%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

1635 watching

Investor Insights

Jun 6, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by many experts, who highlight its strong performance in Asia and robust wealth management services. The company is seen as a good long-term investment, particularly due to its attractive dividend yield and relatively low price-to-earnings ratio compared to banks. However, there are concerns regarding short-term earnings fluctuations, particularly in alternative portfolio results and U.S. operations. Market analysts suggest that while the stock has had a good run, cautious investors should watch for strategic entry points, as some believe it may be susceptible to macroeconomic challenges. Overall, the sentiment is that MFC is a solid income stock with potential for growth as it continues to navigate its complex business landscape.

Consensus

Hold

Valuation

Fair Value

Similar

GWO

HOLD

Stock is finally starting to show some positive technicals. Just had a nice breakout and now has an upward trend. Seasonally should do quite well from Feb to May but hasn’t done that the last few years.

COMMENT

Leveraged play on stock market and interest rates. If you believe rates are going higher in the long run, stock should do well. Long-term prospects are weak. ROE days of 20% are over. It’s now a 10% ROE stock and he wouldn’t pay any more than BV, which is roughly where it is now. (He sold his holdings.)

PAST TOP PICK

(A Top Pick Dec 22/09. Down 21%.) Has faith that they are de-risking the company to a large extent. Hedged out a good portion of the equity exposure and selling a more conservative product. Feels profitability is going to improve.

HOLD

Hoping the worst is behind them. Passage of time will be what the stock needs. Great Asian operation with about 20% of their business coming from there. Trades close to Book.

DON'T BUY

Have some issues. Fairly valued. Needs better stock market environment and better yields. All insurance companies are down. If you own, Sell at around $18 and then Buy back cheaper.

DON'T BUY

Had a major sell off and is still under the trend line. It could likely come back and test the $10 level. Volume is falling and everything is negative.

TOP PICK

Still a lot of questions but likes that they will be concentrating on reducing volatility and risk. A contrarian play.

HOLD

Has been a major disappointment. In “no mans’ land” now and expects it to be a pretty big tax-loss candidate into year-end. Company is fine. If you don’t own, wait to see a little more reduction of their exposure.

COMMENT

Decent earnings report on Nov 4, which beat estimates by a large degree. Starting to see earnings momentum turn a bit but is still below its 200-day moving average and would be a strong consideration if it rose above that.

TOP PICK

Manulife Bonds: 7.405% 12/31/2019 They have gone through the worst. This bonds represents good value on the yield curve.

BUY

Like a warrant on the market. Recovered nicely Sept –Oct and then really got a boost when it announced its 3rd quarter earnings, Still somewhat speculative as they still have a large portion of their book unhedged.

PAST TOP PICK

(A Top Pick Dec 7/09. Down 15%.) Looks like it’s bottomed.

COMMENT

On his Watch list. Was kicking the tires a few months ago. As interest rates go up it should go up because of the mark to market and should also go up as stocks go up. Would prefer it lower down.

PAST TOP PICK

(A Top Pick Oct 22/09. Down 29.88%.) Sold most of his holdings in this. Fully valued.

DON'T BUY

His view has not changed. It went up with equity markets plus Gov’t has not made it as onerous for them to show their hedging and risk level on their balance sheet. A debt-rating agency downgraded them recently by two notches. There was less bad news than expected. The fundamentals that bother him have not changed.

Showing 1,366 to 1,380 of 2,279 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)